<DOC>
	<DOCNO>NCT00779012</DOCNO>
	<brief_summary>The objective study prove reasonability registration Russian federation new indication ( ankylose spondylitis [ AS ] ) evaluation safety efficacy rate Remicade 5mg/kg , give intravenous infusion 2-hour period follow additional 5 mg/kg infusion dose 2 6 week first infusion , every 6 8 week ( maximum 9 infusion ) .</brief_summary>
	<brief_title>A Study Efficacy Tolerance Remicade Treatment Active Ankylosing Spondylitis ( Study P04042 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Patients 18 70 year age . Males female patient reproductive potential ( also include woman postmenopaused &lt; 1 year ) must use reliable birth control method ( abstinence , oral contraceptive , diaphragm prescribe physician , condom use spermicide , surgical sterilization ) 6 month last Remicade infusion . Proven AS accord modify New York criterion imply include patient must pelvic xray show sign sacroiliitis &gt; grade 2 bilateral . Acute phase disease less last 3 month condition everyday intake NSAIDs full daily dosage least 1 month initiation treatment , significant spinal pain ( VAS &gt; 4 ) last week prior inclusion study . In case peripheral joint arthritis besides measure mention absence efficacy least 2times intraarticular injection steroid ( contraindicate well tolerate ) sulfasalazine intake daily dose 23 g least 4 month ( contraindicate well tolerate ) establish . In case enthesitis inflammation besides measure mention absence efficacy least 2times local injection steroid ( contraindicate well tolerate ) establish . Ability comprehend term participation study , willing follow procedure instruction inform consent form sign begin first procedure study ( except several case chest xray ) . Screening prevention latent active TB must perform accord local guideline and/or current SPC alert card . This include PPD test Chest xray perform within 30 day prior initiate treatment Remicade . Pregnant woman , nurse mother plan pregnancy within 6 month last infusion . Patients concurrent systemic inflammatory condition sign symptom might confound evaluation benefit Remicade , e.g . Lyme disease , rheumatic disease ( lupus erythematosus , systemic scleroderma ) joint affection sacroileitis . Prior administration Remicade therapeutic agent target reduce TNF ( e.g. , Etanercept , pentoxifylline , thalidomide antiCD4+ antibody ) within previous 3 month . History known allergy murine protein . Serious infection , hepatitis , pneumonia , pyelonephritis previous 3 month . Less serious infection previous 3 month , acute upper respiratory tract infection ( cold ) uncomplicated urinary tract infection need consider exclusion discretion treat physician . Any chronic infection acute phase , e.g . upper respiratory tract infection localization ( chronic bronchitis , pneumonia , pyelonephritis , cholecystitis , hepatitis etc. ) . Documented HIV infection . Positive hepatitis B C test without clinical sign disease . Current skin psoriasis , nonspecific ulcerative colitis Crohn 's disease . History opportunistic infection herpes zoster within 2 month screen . Evidence active CMV , active pneumocystis carinii , drug resistant atypical mycobacterium infection , etc . Current sign symptom severe , progressive uncontrolled renal , hepatic , hematological , endocrine , pulmonary , cardiac , neurological cerebral disease . Any currently know malignancy premalignant lesion history malignancy within past 5 year . Active and/or latent TB previous history TB . Nonstable dos basic steroid therapy NSAID therapy within 4 week inclusion study . Supportive prednisone therapy &gt; 10 mg/day . Patients moderate severe heart failure ( NYHA class III/IV ) . Septic arthritis ( infected joint implant ) within least last 12 month . Necessity use medicinal product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>